Moyamoya disease: diagnosis and interventions
M Ihara, Y Yamamoto, Y Hattori, W Liu… - The Lancet …, 2022 - thelancet.com
Moyamoya disease is a rare cause of stroke, radiologically characterised by progressive
stenosis of the terminal portion of the internal carotid arteries and compensatory capillary …
stenosis of the terminal portion of the internal carotid arteries and compensatory capillary …
[HTML][HTML] The pathophysiology of moyamoya disease: an update
Moyamoya disease (MMD) is a unique cerebrovascular disease characterized by the
progressive stenosis of large intracranial arteries and a hazy network of basal collaterals …
progressive stenosis of large intracranial arteries and a hazy network of basal collaterals …
Moyamoya disease
M Fujimura, OY Bang, JS Kim - … : Pathophysiology, Diagnosis and …, 2016 - karger.com
Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease characterized by
progressive stenosis at the terminal portion of the internal carotid artery and an abnormal …
progressive stenosis at the terminal portion of the internal carotid artery and an abnormal …
[HTML][HTML] RNF213 and GUCY1A3 in moyamoya disease: key regulators of metabolism, inflammation, and vascular stability
Y Mineharu, S Miyamoto - Frontiers in Neurology, 2021 - frontiersin.org
Moyamoya disease is an idiopathic chronically progressive cerebrovascular disease, which
causes both ischemic and hemorrhagic stroke. Genetic studies identified RNF213/Mysterin …
causes both ischemic and hemorrhagic stroke. Genetic studies identified RNF213/Mysterin …
Moyamoya Disease and Spectrums of RNF213 Vasculopathy
Moyamoya disease (MMD) is a rare cerebrovascular disease characterized by progressive
stenosis of large intracranial arteries and a hazy network of basal collaterals called …
stenosis of large intracranial arteries and a hazy network of basal collaterals called …
Genetic Variant RNF213 c.14576G>A in Various Phenotypes of Intracranial Major Artery Stenosis/Occlusion
S Miyawaki, H Imai, M Shimizu, S Yagi, H Ono… - Stroke, 2013 - Am Heart Assoc
Background and Purpose—Recently, we reported a common genetic variant, ring finger
protein 213 (RNF213) c. 14576G> A variant, a susceptibility gene for moyamoya disease …
protein 213 (RNF213) c. 14576G> A variant, a susceptibility gene for moyamoya disease …
[HTML][HTML] Novel multifaceted roles for RNF213 protein
G Pollaci, G Gorla, A Potenza, T Carrozzini… - International Journal of …, 2022 - mdpi.com
Ring Finger Protein 213 (RNF213), also known as Mysterin, is the major susceptibility factor
for Moyamoya Arteriopathy (MA), a progressive cerebrovascular disorder that often leads to …
for Moyamoya Arteriopathy (MA), a progressive cerebrovascular disorder that often leads to …
[HTML][HTML] A new horizon of moyamoya disease and associated health risks explored through RNF213
A Koizumi, H Kobayashi, T Hitomi, KH Harada… - … health and preventive …, 2016 - Springer
The cerebrovascular disorder moyamoya disease (MMD) was first described in 1957 in
Japan, and is typically considered to be an Asian-specific disease. However, it is globally …
Japan, and is typically considered to be an Asian-specific disease. However, it is globally …
[HTML][HTML] Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians
Moyamoya angiopathy (MMA) is a cerebral angiopathy affecting the terminal part of internal
carotid arteries. Its prevalence is 10 times higher in Japan and Korea than in Europe. In East …
carotid arteries. Its prevalence is 10 times higher in Japan and Korea than in Europe. In East …
[HTML][HTML] Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state
Moyamoya disease is an idiopathic human cerebrovascular disorder that is characterized by
progressive stenosis and abnormal collateral vessels. We recently identified …
progressive stenosis and abnormal collateral vessels. We recently identified …